Published in Clin Endocrinol (Oxf) on August 01, 1996
IGF1R variants associated with isolated single suture craniosynostosis. Am J Med Genet A (2011) 0.92
Sequencing analysis of insulin receptor defects and detection of two novel mutations in INSR gene. Mol Genet Metab Rep (2014) 0.76
Homozygous mutation in the insulin receptor. Clin Endocrinol (Oxf) (1996) 0.75
Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest (1977) 2.46
Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J Biol Chem (2001) 1.67
Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. Cancer Res (1984) 1.40
Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development. Proc Natl Acad Sci U S A (1986) 1.27
Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor. J Biol Chem (1998) 1.19
The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts. J Clin Endocrinol Metab (1987) 1.17
Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Res (1989) 1.15
Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes Sl/Sld and W/Wv). Cancer Res (1992) 1.14
The somatomedin C binding protein: evidence for a heterologous subunit structure. J Clin Endocrinol Metab (1980) 1.13
Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors. Int J Cancer (1987) 1.11
Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. J Clin Endocrinol Metab (1991) 1.07
Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor. Biochem Biophys Res Commun (2000) 1.03
A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Am J Dis Child (1987) 1.03
High affinity antibody from hen's eggs directed against the human insulin receptor and the human IGF-I receptor. Anal Biochem (1988) 1.00
Fibroblasts from a patient with leprechaunism are resistant to insulin, epidermal growth factor, and somatomedin C. J Clin Endocrinol Metab (1982) 0.98
Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR. J Biol Chem (1995) 0.98
Steroid cell tumor of the ovary in a child. Arch Pathol Lab Med (1991) 0.97
Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10. Mol Endocrinol (1996) 0.97
Ovine placental lactogen induces somatomedin: a a possible role in fetal growth. Endocrinology (1977) 0.96
Third-year medical student survey of office preceptorships during the pediatric clerkship. Arch Pediatr Adolesc Med (2001) 0.95
Pitfalls in the somatomedin-C radioimmunoassay. J Clin Endocrinol Metab (1982) 0.95
Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy. J Clin Endocrinol Metab (1990) 0.94
Radioimmunoassay of vasopressin in familial cental diabetes insipidus. J Pediatr (1982) 0.93
Stimulation of DNA synthesis by ouabain and concanavalin A in cultures of embryonic neural retina cells. Cell Differ (1976) 0.91
Altered blood pressure reactivity in adolescent diabetics. Pediatrics (1994) 0.90
Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature. J Clin Endocrinol Metab (1984) 0.87
Lectin-mediated stimulation of DNA synthesis in cultures of embryonic neural retina cells. Exp Cell Res (1976) 0.86
Radioimmunoassay of somatomedin C/insulin-like growth factor I. Methods Enzymol (1987) 0.84
Growth factor binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors from rats subject to chronic caloric restriction. Cancer Res (1989) 0.84
Evidence that somatomedin-C is degraded by the kidney and inhibits insulin degradation. Endocrinology (1977) 0.83
Nuclear phosphoproteins. 3. Increase in phosphory- lation during histone-phosphoprotein interaction. Biochim Biophys Acta (1971) 0.82
Enhancement of linear growth and weight gain by cyproheptadine in children with hypopituitarism receiving growth hormone therapy. J Pediatr (1987) 0.82
Peripheral resistance to thyroid hormone in an infant. J Clin Endocrinol Metab (1981) 0.81
Regulation of oligodendrocyte development by insulin-like growth factors and cyclic nucleotides. Ann N Y Acad Sci (1990) 0.81
Size discrepancy between somatomedin-C and insulin receptors. J Clin Endocrinol Metab (1984) 0.81
Serum immunoreactive somatomedin-C is elevated late in pregnancy. J Clin Endocrinol Metab (1978) 0.81
Stimulation of DNA synthesis by concanavalin A in cultures of embryonic neural retina cells. Biochem Biophys Res Commun (1973) 0.80
Synergistic actions of estradiol and the insulin-like growth factor somatomedin-C on swine ovarian (granulosa) cells. Endocrinology (1986) 0.80
The somatomedin group of peptide growth factors. Natl Cancer Inst Monogr (1978) 0.80
Nuclear binding of [125I]triiodothyronine in dispersed cultured skin fibroblasts from patients with resistance to thyroid hormone. J Clin Endocrinol Metab (1982) 0.79
Discordant metabolic actions of insulin in extreme lipodystrophy of childhood. J Clin Endocrinol Metab (1993) 0.79
Comparison of transdermal and oral estrogen therapy in girls with Turner's syndrome. J Pediatr Endocrinol Metab (1995) 0.79
Stimulation of embryonic mouse limb bud mesenchymal cell growth by peptide growth factors. J Cell Physiol (1982) 0.78
Glucocorticoids enhance somatomedin-C binding and stimulation of amino acid uptake in human fibroblasts. J Clin Endocrinol Metab (1987) 0.78
Trophic actions of human somatomedin C/insulin-like growth factor I on ovarian cells: in vitro studies with swine granulosa cells. Endocrinology (1985) 0.78
Wheat germ agglutinin and concanavalin A inhibit the response of human fibroblasts to peptide growth factors by a post-receptor mechanism. J Cell Physiol (1985) 0.77
If gonadotropin-releasing hormone plus growth hormone (GH) really improves growth outcomes in short non-GH-deficient children, then what? J Clin Endocrinol Metab (2001) 0.77
Virilizing adrenal tumor in a 3-year-old girl: diagnosis by computed tomographic scan and ultrasound. Am J Dis Child (1983) 0.77
Deletion of 3 basepairs resulting in the loss of lysine-121 in the insulin receptor alpha-subunit in a patient with leprechaunism: binding, phosphorylation, and biological activity. J Clin Endocrinol Metab (1994) 0.76
A monoclonal antibody to the type 1 insulin-like growth factor and insulin receptors stimulates deoxyribonucleic acid synthesis in human and murine fibroblasts. Endocrinology (1988) 0.76
Decreased serum somatomedin C concentrations during sleep: temporal relationship to the nocturnal surges of growth hormone and prolactin. J Clin Endocrinol Metab (1981) 0.75
Mechanisms subserving insulin action in the gonad: evidence that insulin induces specific phosphorylation of its immunoprecipitable receptor on ovarian cells. Biochem Biophys Res Commun (1984) 0.75
Aryl alpha-haloalkyl ketoximes as enzyme modifying agents. The reaction of alpha-haloacetophenone oximes with the active site of papain. Biochem Biophys Res Commun (1974) 0.75
Symposium summary, Experimental Biology 2001. J Investig Med (2001) 0.75
Characterization of insulin-like growth factor receptors in the insulin-responsive R3230AC mammary adenocarcinoma. Oncol Res (1992) 0.75
The somatomedin-C receptor of human placenta. Metabolism (1984) 0.75
Deletion of lysine 121 creates a temperature-sensitive alteration in insulin binding by the insulin receptor. J Biol Chem (1995) 0.75
Plasma somatomedin-C during the first year of life. J Pediatr (1982) 0.75
The insulin receptor of embryonic chicken cartilage. Endocrinology (1979) 0.75
Cyclic nucleotides and somatomedin action in cartilage. Endocrinology (1982) 0.75
Cushing's syndrome resulting from primary pigmented nodular adrenocortical disease. Am J Dis Child (1986) 0.75
Reaction of the active site of papain with a "reporter" group labeled phenacyl halide. J Am Chem Soc (1970) 0.75
Chronobiologic considerations in human growth hormone therapy. J Pediatr (1983) 0.75
Ambiguity of the external genitalia in an infant with Down syndrome: gender assignment and ethical implications. Ment Retard (1999) 0.75
Premature adrenarche. Clinical and diagnostic features. Clin Pediatr (Phila) (1986) 0.75
Somatomedin-C/insulin-like growth factor-I as a modulator of growth during childhood and adolescence. Horm Res (1986) 0.75
The effect of sex steroids on radioimmunoassayable plasma somatomedin C concentrations. J Clin Endocrinol Metab (1982) 0.75
Sepsis in leukemia. J Pediatr (1979) 0.75
Plasma insulin-like growth factor I levels during treatment of congenital adrenal hyperplasia. Horm Res (1990) 0.75
Stimulation by somatomedin-C of aminoisobutyric acid uptake in human fibroblasts: a possible test for cellular responsiveness to somatomedin. J Clin Endocrinol Metab (1984) 0.75
Conditional responsiveness of a chemically transformed cell line to growth factor stimulated DNA synthesis. J Cell Physiol (1987) 0.75
The mammalian cell cycle in normal and abnormal growth. Endocrinol Metab Clin North Am (1996) 0.75
Transient growth hormone deficiency after treatment of primary hypothyroidism. J Pediatr (1987) 0.75